Psychedelic medicine is used in a variety of therapies and may include MDMA, ketamine, psilocybin mushrooms, LSD, peyote, and even cannabis. As with any niche industry still in its infancy, the risks are high. Many companies, including pharmaceutical manufacturers, treatment centers and clinics, and businesses offering wellness and nutraceutical products using psychoactive ingredients, such as micro-dosing psilocybin, are finding it difficult to find the right coverages or any coverage at all. Some insurers may provide a drug-specific policy, usually for drugs that are approved for use by the FDA but will not cover drugs that aren't FDA approved.

​

Rahn & Associates provides specialty lines of insurance products and services for highly regulated and complex industries such as psychedelic medicine. If you have questions regarding the specific products or treatments your business provides and what is required to be adequately protected, please contact Rahn & Associates for a consultation at (954) 790-6604 or email info@rahn-associates.com